Scynexis (SCYX) Other Non-Current Assets (2013 - 2026)
Scynexis (SCYX) posted Other Non-Current Assets of $109000.0 for Q1 2026, little changed on a QoQ basis from $109000.0 in Q4 2025, and little changed year-over-year from $109000.0 in Q1 2025.
Scynexis (SCYX) Other Non-Current Assets (2013 - 2026) Analysis & Trends
Scynexis' Other Non-Current Assets history runs 14 years deep, the most recent figure standing at $109000.0 for Q1 2026.
- Quarterly Other Non-Current Assets changed 0.0% year-over-year to $109000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $109000.0 (changed 0.0% YoY) and the FY2025 annual result came in at $109000.0, changed 0.0% from the prior year.
- Other Non-Current Assets was $109000.0 for Q1 2026 at Scynexis, roughly flat from $109000.0 in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $6.1 million in Q2 2022 and bottomed at $25000.0 in Q3 2023.
- A 5-year average of $1.4 million and a median of $163000.0 in 2023 frame the typical range for Other Non-Current Assets.
- Annual changes were most pronounced in 2022 — Other Non-Current Assets soared 2228.44% — and 2023, when it slumped 99.51%.
- Scynexis' Other Non-Current Assets stood at $5.5 million in 2022, then plunged by 97.04% to $163000.0 in 2023, then tumbled by 33.13% to $109000.0 in 2024, then changed by 0.0% to $109000.0 in 2025, then changed by 0.0% to $109000.0 in 2026.
- Business Quant data shows SCYX's Other Non-Current Assets at $109000.0 in Q1 2026, $109000.0 in Q4 2025, and $109000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 49.22 Mn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 1.79 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 351.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 491.06 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 233.20 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.11 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 73.60 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 295.00 Mn |
| 10 | Scynexis | 21.55 Mn | -15.20 Mn | - | 109,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 109,000.00 |
| Dec 31, 2025 | 109,000.00 |
| Sep 30, 2025 | 109,000.00 |
| Jun 30, 2025 | 109,000.00 |
| Mar 31, 2025 | 109,000.00 |
| Dec 31, 2024 | 109,000.00 |
| Sep 30, 2024 | 109,000.00 |
| Jun 30, 2024 | 163,000.00 |
| Mar 31, 2024 | 163,000.00 |
| Dec 31, 2023 | 163,000.00 |
| Sep 30, 2023 | 25,000.00 |
| Jun 30, 2023 | 163,000.00 |
| Mar 31, 2023 | 163,000.00 |
| Dec 31, 2022 | 5.51 Mn |
| Sep 30, 2022 | 5.08 Mn |
| Jun 30, 2022 | 6.08 Mn |
| Mar 31, 2022 | 5.54 Mn |
| Dec 31, 2021 | 6.24 Mn |
| Sep 30, 2021 | 218,000.00 |
| Jun 30, 2021 | 1.41 Mn |